TP53 and cancer: These pathway enrichment analysis results from different focuses suggested that there were significant differences in the activities of pathways in the observation stage and the relapsed post-CIT, especially the TP53 signaling pathway and energy metabolism pathway, which were closely related to malignant tumors.